High-Sulfated Glycosaminoglycans Prevent Coronavirus Replication

Coronaviruses (CoVs) are common among humans and many animals, causing respiratory or gastrointestinal diseases. Currently, only a few antiviral drugs against CoVs are available. Especially for SARS-CoV-2, new compounds for treatment of COVID-19 are urgently needed. In this study, we characterize th...

Descripción completa

Detalles Bibliográficos
Autores principales: Möller, Stephanie, Theiß, Janine, Deinert, Thaira I. L., Golat, Karoline, Heinze, Julian, Niemeyer, Daniela, Wyrwa, Ralf, Schnabelrauch, Matthias, Bogner, Elke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8877876/
https://www.ncbi.nlm.nih.gov/pubmed/35216006
http://dx.doi.org/10.3390/v14020413

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8877876/
https://www.ncbi.nlm.nih.gov/pubmed/35216006
http://dx.doi.org/10.3390/v14020413

Ejemplares similares